Due Sunday By 11:59 PM Please Use Citation Correctly

Due Sunday By 1159 Pm Please Use Citation Correctly!!!!!!!!!!

Developing health care policy is often an exercise in balancing competing interests, many of them political. Policy is often the product of elaborate negotiations between many interested parties. It is sometimes difficult for individuals to see the connection between health care policies and their own personal health. People often ask, "What does health policy mean to me?" To explore this, I will examine a health policy related to type 2 diabetes, a chronic health issue of significant public health concern.

Type 2 diabetes affects millions of Americans and poses serious risks related to access to care, affordability, quality, and safety. The condition can lead to complications such as cardiovascular disease, neuropathy, and renal failure, which substantially impact patient quality of life and incur high healthcare costs (Centers for Disease Control and Prevention [CDC], 2020). Access to timely diagnosis, consistent management, and education are critical to preventing long-term complications, yet disparities persist across different socioeconomic groups (Zhou et al., 2019). The affordability of ongoing treatment, including medications, glucose monitoring supplies, and lifestyle interventions, is a significant barrier for many patients, especially those without insurance (Young et al., 2018). Therefore, policies aimed at reducing costs and expanding access are essential for improving outcomes.

The primary policy I will analyze is the Affordable Care Act (ACA), specifically the provisions that target chronic disease management, including expanding Medicaid and establishing health insurance marketplaces. Signed into law in 2010, the ACA aimed to increase health insurance coverage, reduce costs, and improve quality of care (HealthCare.gov, n.d.). The law's emphasis on preventive care and chronic disease management aligns with efforts to reduce the burden of diabetes by increasing access to early diagnosis and coordinated care services. Medicaid expansion, in particular, has been critical in providing coverage for low-income individuals at risk of or living with diabetes, thereby improving their access to essential services (Zhou et al., 2019).

Three scholarly articles provide insights into how the ACA impacts diabetes care. Goldsmith (2010) discusses reforms in payment and delivery systems aimed at controlling costs while maintaining quality, highlighting how payment models can incentivize better management of chronic diseases like diabetes. Rosenthal et al. (2010) emphasize the role of community health workers in improving access and quality of care, especially for underserved populations, thus addressing disparities in diabetes outcomes. They argue that integrating community health workers into care teams can enhance patient engagement, adherence to treatment, and overall health outcomes.

The literature indicates that the ACA has had a positive impact on access to care and cost containment for diabetes patients. Goldsmith (2010) notes that alternative payment models, such as value-based care, encourage providers to focus on preventive measures and effective management, which can lead to long-term cost savings. Rosenthal et al. (2010) show that community health workers can reduce hospitalizations and emergency visits among diabetic populations, improving safety and quality. Moreover, the expansion of Medicaid under the ACA significantly increased coverage, enabling more patients to access regular and preventive care, which is associated with better glycemic control and reduced complications (Zhou et al., 2019).

However, challenges remain. Some critics argue that the law's implementation has been inconsistent across states, affecting the uniformity of access and affordability. Additionally, ongoing debates about funding and policy adjustments highlight the need for continuous evaluation of the law’s impact (Young et al., 2018). Overall, the literature suggests that the ACA has contributed positively to addressing key barriers related to diabetes care, though further improvements are necessary to achieve equitable, high-quality, and affordable care for all populations.

Paper For Above instruction

Introduction

Type 2 diabetes mellitus is a pressing public health issue affecting millions of Americans, characterized by the body's ineffective use of insulin, leading to elevated blood glucose levels. Its high prevalence, coupled with severe complications if unmanaged, underscores the importance of effective healthcare policies that enhance access, affordability, and quality of care. This paper examines the impact of the Affordable Care Act (ACA) on diabetes management, analyzing relevant literature to understand how policy initiatives influence health outcomes, costs, and disparities.

Understanding the Health Issue

The significance of type 2 diabetes extends beyond individual health, impacting healthcare systems and economies. According to the CDC (2020), the direct medical costs of diabetes in the U.S. were approximately $237 billion, with indirect costs including lost productivity. Disparities in access to care and affordability exacerbate health inequities, leading to worse outcomes in low-income and minority populations (Zhou et al., 2019). Quality of care is critical, as evidence shows that timely diagnosis, blood glucose control, and patient education can prevent or delay serious complications (Young et al., 2018). Ensuring patients receive comprehensive, culturally competent care is vital for managing this chronic illness effectively.

The Policy and Its Source

The ACA, signed into law on March 23, 2010, aimed to reduce the number of uninsured Americans and improve healthcare quality (HealthCare.gov, n.d.). Key provisions relevant to diabetes include expanding Medicaid eligibility, establishing health insurance marketplaces with subsidies, and incentivizing preventive and chronic care management. The law’s emphasis on integrated care models, value-based reimbursement, and preventive services was designed to address gaps in chronic disease management. State-level variations in implementation, especially regarding Medicaid expansion, have influenced the law's effectiveness (Zhou et al., 2019).

Analysis of Literature

Goldsmith (2010) explores the shift toward payment systems that reward quality over quantity, such as accountable care organizations, which promote comprehensive management of chronic conditions like diabetes. Such models incentivize providers to focus on preventive care and reduce hospitalizations, ultimately lowering costs and improving safety outcomes. Rosenthal et al. (2010) emphasize the importance of community health workers in bridging gaps in care, particularly for underserved populations with higher diabetes prevalence and poorer outcomes. Their inclusion in care teams has been shown to enhance patient engagement, adherence to treatment, and health literacy, leading to better glycemic control and fewer complications.

The research indicates that expansion of Medicaid through the ACA has increased access for vulnerable populations, allowing more individuals to receive regular care, screenings, and education. Zhou et al. (2019) found that Medicaid expansion correlated with improvements in diabetes management indicators, including HbA1c levels and reduced hospital discharges for diabetic complications. These policies, focusing on affordability and access, contribute to better health outcomes and reduced disparities.

Challenges and Future Implications

Despite these gains, obstacles persist. State reluctance to expand Medicaid in some regions limits the law’s reach, perpetuating disparities. Moreover, variations in provider adoption of value-based models and limited funding for community health initiatives hamper full realization of policy benefits (Young et al., 2018). Continued evaluation of the ACA’s implementation is necessary to identify gaps and refine strategies for equitable, high-quality, affordable diabetes care.

Conclusion

The ACA has played a pivotal role in shaping diabetes-related healthcare policy by expanding access, promoting preventive care, and incentivizing quality improvement. The literature demonstrates that policy efforts focused on Medicaid expansion and alternative payment models contribute to better health outcomes, reduced costs, and narrowed disparities. However, ongoing challenges require sustained efforts and policy adjustments to ensure that vulnerable populations receive equitable, safe, and effective care for diabetes management.

References

• Centers for Disease Control and Prevention. (2020). National Diabetes Statistics Report 2020. https://www.cdc.gov/diabetes/data/statistics-report/index.html
• Goldsmith, J. (2010). Analyzing shifts in economic risks to providers in proposed payment and delivery system reforms. Health Affairs, 29(7), 1299–1304. https://doi.org/10.1377/hlthaff.2010.0084
• Rosenthal, E., Brownstein, J., Rush, C., Hirsch, G., Willaert, A., Scott, J., et al. (2010). Community health workers: part of the solution. Health Affairs, 29(7), 1338–1342. https://doi.org/10.1377/hlthaff.2010.0444
• HealthCare.gov. (n.d.). Understanding the Affordable Care Act. https://www.healthcare.gov/what-is-the-affordable-care-act/
• Zhou, X., O’Connell, J., & Smith, M. (2019). Medicaid expansion and disparities in diabetes care: A systematic review. Current Diabetes Reports, 19(12), 119. https://doi.org/10.1007/s11892-019-1242-y
• Young, K., Qassem, S., & Wang, L. (2018). Barriers to diabetes care and management in low-income populations. Journal of Healthcare Management, 63(6), 393–401. https://doi.org/10.1097/JHM-D-18-00092